Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure AwarenessHeart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissions Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jan 18 2021 | Heart Failure Awareness 365: Research, Clinical Trials, and Patient Advocacy Patient News Heart Failure Awareness Patient Resource Read More Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More Jan 10 2021 | HFSA President's Update: January 2021 HFSA News President's Updates Read More Dec 22 2020 | Heart Failure Society of America Reassures Patients on Safety of COVID-19 Vaccine HFSA News Coronavirus In The News Patient Resource Read More Dec 22 2020 | Remembering Former HFSA President Thomas Force, MD HFSA News HFSA Membership Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Jan 18 2021 | Heart Failure Awareness 365: Research, Clinical Trials, and Patient Advocacy Patient News Heart Failure Awareness Patient Resource Read More
Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More
Dec 22 2020 | Heart Failure Society of America Reassures Patients on Safety of COVID-19 Vaccine HFSA News Coronavirus In The News Patient Resource Read More
